CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

tev-48574

mAbexperimental

Clinical trial activity

7 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
7
Phase 3
4
Phase 4
0

Earliest trial started Aug 26, 2020 (NCT04545385)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07184944Phase 3Jan 29, 2026Sanofi, Teva
NCT07185009Phase 3Jan 7, 2026Sanofi, Teva
NCT07184996Phase 3Oct 8, 2025Sanofi, Teva
NCT07184931Phase 3Oct 1, 2025Sanofi, Teva
NCT05668013Phase 2Jan 6, 2023Teva
NCT05499130Phase 2Aug 29, 2022Teva
NCT04545385Phase 2Aug 26, 2020Teva
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TevaFor profit7322020
SanofiFor profit4412025
2 organizations
Page 1 / 1